Abstract
This report reviews the evidence for and against clinical use of ambulatory blood pressure monitoring (ABPM) on a large scale. Such monitoring is supported by a number of data, among which is that the end-organ damage associated with hypertension correlates more with 24-h average blood pressure than with clinic blood pressure, the correlation becoming even closer with addition of blood pressure variability values. However the evidence thus far collected is largely cross-sectional. Furthermore, ABPM devices have limited accuracy and the procedure has a high cost. Therefore, while prospective studies on the prognostic value of ambulatory blood pressure are awaited, use of this approach should be restricted to a limited number of clinical circumstances (e.g., identification of white-coat hypertension) and used only in specialized centers.
| Original language | English |
|---|---|
| Journal | Journal of Cardiovascular Pharmacology |
| Volume | 23 |
| Issue number | SUPPL. 5 |
| Publication status | Published - 1994 |
Fingerprint
Keywords
- ABPM
- End-organ damage
- Hypertension
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine
- Pharmacology
Cite this
Clinical value of ambulatory blood pressure monitoring. / Mancia, G.; Santucciu, C.; Ulian, L.; Gelosa, M.; Rivolta, M. R.; Sega, R.
In: Journal of Cardiovascular Pharmacology, Vol. 23, No. SUPPL. 5, 1994.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Clinical value of ambulatory blood pressure monitoring
AU - Mancia, G.
AU - Santucciu, C.
AU - Ulian, L.
AU - Gelosa, M.
AU - Rivolta, M. R.
AU - Sega, R.
PY - 1994
Y1 - 1994
N2 - This report reviews the evidence for and against clinical use of ambulatory blood pressure monitoring (ABPM) on a large scale. Such monitoring is supported by a number of data, among which is that the end-organ damage associated with hypertension correlates more with 24-h average blood pressure than with clinic blood pressure, the correlation becoming even closer with addition of blood pressure variability values. However the evidence thus far collected is largely cross-sectional. Furthermore, ABPM devices have limited accuracy and the procedure has a high cost. Therefore, while prospective studies on the prognostic value of ambulatory blood pressure are awaited, use of this approach should be restricted to a limited number of clinical circumstances (e.g., identification of white-coat hypertension) and used only in specialized centers.
AB - This report reviews the evidence for and against clinical use of ambulatory blood pressure monitoring (ABPM) on a large scale. Such monitoring is supported by a number of data, among which is that the end-organ damage associated with hypertension correlates more with 24-h average blood pressure than with clinic blood pressure, the correlation becoming even closer with addition of blood pressure variability values. However the evidence thus far collected is largely cross-sectional. Furthermore, ABPM devices have limited accuracy and the procedure has a high cost. Therefore, while prospective studies on the prognostic value of ambulatory blood pressure are awaited, use of this approach should be restricted to a limited number of clinical circumstances (e.g., identification of white-coat hypertension) and used only in specialized centers.
KW - ABPM
KW - End-organ damage
KW - Hypertension
UR - http://www.scopus.com/inward/record.url?scp=0028659157&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0028659157&partnerID=8YFLogxK
M3 - Article
C2 - 7609493
AN - SCOPUS:0028659157
VL - 23
JO - Journal of Cardiovascular Pharmacology
JF - Journal of Cardiovascular Pharmacology
SN - 0160-2446
IS - SUPPL. 5
ER -